Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.

Bibliographic Details
Main Author: Lee, R
Format: Journal article
Language:English
Published: 2012
_version_ 1797066126293729280
author Lee, R
author_facet Lee, R
author_sort Lee, R
collection OXFORD
description
first_indexed 2024-03-06T21:37:56Z
format Journal article
id oxford-uuid:46e788e0-d364-4ba1-a661-28cebb61dc3b
institution University of Oxford
language English
last_indexed 2024-03-06T21:37:56Z
publishDate 2012
record_format dspace
spelling oxford-uuid:46e788e0-d364-4ba1-a661-28cebb61dc3b2022-03-26T15:16:43ZPreanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:46e788e0-d364-4ba1-a661-28cebb61dc3bEnglishSymplectic Elements at Oxford2012Lee, R
spellingShingle Lee, R
Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title_full Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title_fullStr Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title_full_unstemmed Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title_short Preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome.
title_sort preanalytic considerations for using plasma myeloperoxidase as a biomarker in acute coronary syndrome
work_keys_str_mv AT leer preanalyticconsiderationsforusingplasmamyeloperoxidaseasabiomarkerinacutecoronarysyndrome